banner
  • Sample Release Agent

    Wothandizira Wotulutsa Zitsanzo

    -Zosavuta kugwiritsa ntchito: zitsanzo za lysis pamene mukutolera zitsanzo

    -Yofulumira komanso yabwino: Palibe chifukwa chochotsa nucleic acid, yoyenera kuzindikira kwakukulu

    -Kuchuluka kwa ntchito: PCR molunjika pambuyo pakutolera zitsanzo

    - Otetezeka komanso odalirika: yambitsani kachilomboka mwachangu, tsimikizirani chitetezo kwambiri

    foregene strength

  • SARS-CoV-2 Variant Nucleic Acid Detection Kit (I) (Multiplex PCR Fluorescent Probe Method)-for detection of mutants from Brazil,South Africa, and UK

    SARS-CoV-2 Variant Nucleic Acid Detection Kit (I) (Multiplex PCR Fluorescent Probe Method)-pozindikira masinthidwe ochokera ku Brazil, South Africa, ndi UK

    Zidazi zimagwiritsa ntchito ukadaulo wa Real-time RT PCR (rRT-PCR) pozindikira za SARS-CoV-2 ndi mizere yosiyana ya nucleic acidsin ma nasopharyngeal amunthu kapena oropharyngeal swab zitsanzo monga SARS-CoV-2 B.1.1.7 mzere (UK) , B.1.351 mzere (ZA) ndi P.1 mzere (BR).

    Chidachi ndi chophatikizira cha zida zoyeretsera ma nucleic acid ndi zida zodziwira za RT-qPCR za SARS-CoV-2 Variant nucleic acid.Choncho palibe chifukwa nucleic asidi kuyeretsedwa, ndi ndalama.imatha kumaliza mayeso mu ola limodzi, makamaka oyenera kuzindikira mwachangu.

    foregene strength

    Zaka 20+ za R&D Production Experience 25+ chinthu chokhudza kwambiri

    1000+ ma reagents osiyanasiyana a lab 100+ ogwirizana nawo mayunivesite

    400+ ogawa 2000+ SCI zolemba za ma reagents a lab

  • SARS-CoV-2 Variant Nucleic Acid Detection Kit II (Multiplex PCR Fluorescent Probe Method)-for detection of variants from UK,South Africa, Brazil, and India

    SARS-CoV-2 Variant Nucleic Acid Detection Kit II (Multiplex PCR Fluorescent Probe Method) -pozindikira mitundu yosiyanasiyana kuchokera ku UK, South Africa, Brazil, ndi India

    Zidazi zimagwiritsa ntchito ukadaulo wa Real-time RT PCR (rRT-PCR) pozindikira za SARS-CoV-2 ndi mizere yosiyana ya nucleic acid mu zitsanzo za nasopharyngeal kapena oropharyngeal swab monga SARS-CoV-2 B.1.1.7 mzere (UK ), B.1.351 mzere (ZA), B.1.617 mzere (IND) ndi P.1 mzere (BR).

    Chidachi ndi chophatikizira cha zida zoyeretsera ma nucleic acid ndi zida zodziwira za RT-qPCR za SARS-CoV-2 Variant nucleic acid.Choncho palibe chifukwa nucleic asidi kuyeretsedwa, ndi ndalama.imatha kumaliza mayeso mu ola limodzi, makamaka oyenera kuzindikira mwachangu.

    foregene strength

  • SARS-CoV-2 Variant Nucleic Acid Detection Kit III (Multiplex PCR Fluorescent Probe Method)-for detection of Delta mutants

    SARS-CoV-2 Variant Nucleic Acid Detection Kit III (Multiplex PCR Fluorescent Probe Method) -pozindikira zosintha za Delta

    Chidachi chimagwiritsa ntchito ukadaulo wa Real-time RT PCR (rRT-PCR) pozindikira zamtundu wa SARS-CoV-2 ndi B.1.617 lineages (IND) ma nucleic acid mu zitsanzo za nasopharyngeal kapena oropharyngeal swab.

    Chidachi ndi chophatikizira cha zida zoyeretsera ma nucleic acid ndi zida zodziwira za RT-qPCR za SARS-CoV-2 Variant nucleic acid.Chifukwa chake palibe chifukwa choyeretsera ma nucleic acid, mutha kumaliza mayeso mu ola limodzi, makamaka oyenera kuzindikira mwachangu.

    foregene strength

  • SARS-CoV-2 Nucleic Acid Detection Kit (Multiplex PCR Fluorescent Probe Method)

    SARS-CoV-2 Nucleic Acid Detection Kit (Multiplex PCR Fluorescent Probe Njira)

    Chidachi chimagwiritsa ntchito ukadaulo wa Real-time RT PCR(rRT-PCR) pozindikira bwino za SARS-CoV-2 (ORF1ab gene ndi N gene) ma nucleic acid mu zitsanzo za nasopharyngeal kapena oropharyngeal swab za anthu, pogwiritsa ntchito njira yofufuzira ya multiplex PCR fulorosenti. Kuwongolera kwamkati kuyesa mtundu wa zitsanzo, kotero kuti palibe chifukwa choyeretsera ma nucleic acid, kumatha kuyesedwa mu ola limodzi, makamaka koyenera kuzindikira mwachangu.

    foregene strength